High prevalence of factor V R506Q mutation in German thrombophilic and normal population

被引：0
|
作者：
Ehrenforth, S [1 ]
Zwinge, B [1 ]
Scharrer, I [1 ]
机构：
[1] Univ Frankfurt, Dept Internal Med, D-60596 Frankfurt, Germany
来源：
THROMBOSIS AND HAEMOSTASIS | 1998年 / 79卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：684 / 685
页数：2
相关论文
共 50 条
  • [41] Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and factor V R506Q mutation
    Castaman, G
    Ruggeri, M
    Tosetto, A
    Rodeghiero, F
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 57 (04) : 344 - 347
  • [42] Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders
    Press, RD
    Bauer, KA
    Kujovich, JL
    Heit, JA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2002, 126 (11) : 1304 - 1318
  • [43] Impact of the factor II:: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V:: R506Q mutation
    Rintelen, C
    Pabinger, I
    Bettelheim, P
    Lechner, K
    Kyrle, PA
    Knöbl, P
    Schneider, B
    Mannhalter, C
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 67 (03) : 165 - 169
  • [44] A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype
    Bernardi, F
    Faioni, EM
    Castoldi, E
    Lunghi, B
    Castaman, G
    Sacchi, E
    Mannucci, PM
    BLOOD, 1997, 90 (04) : 1552 - 1557
  • [45] High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A
    Federici, Elizabeth H.
    Al-Mondhiry, Hamid
    THROMBOSIS RESEARCH, 2019, 182 : 75 - 78
  • [46] Activated protein C resistance due to factor V R506Q mutation is associated with placental insufficiency and recurrent fetal loss.
    Brenner, B
    Mandel, H
    Lanir, N
    Younis, J
    Ohel, G
    Blumenfeld, Z
    BLOOD, 1995, 86 (10) : 806 - 806
  • [47] Venous thrombosis in elderly: Prevalence of factor V gene mutation Q506
    Andre, E
    AlhenceGelas, M
    Siguret, V
    Gaussem, P
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1262 - P1262
  • [48] Factor V Q 506 mutation in children with thrombosis
    Gurgey, A
    Mesci, L
    Renda, Y
    Olcay, L
    Kocak, N
    Erdem, G
    AMERICAN JOURNAL OF HEMATOLOGY, 1996, 53 (01) : 37 - 39
  • [49] Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection
    Ekberg, H
    Svensson, PJ
    Simanaitis, M
    Dahlbäck, B
    TRANSPLANTATION, 2000, 69 (08) : 1577 - 1581
  • [50] Paget-Schroetter syndrome after a dental procedure in a patient with factor V Leiden (R506Q) heterozygosity
    Sharma, Prabin
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (03) : 269 - 271
12345